Literature DB >> 17098818

Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4.

Carl F Fortin1, Olivier Lesur, Tamas Fulop.   

Abstract

Neutrophilic polymorphonuclears (PMNs) play an important role in the progression of sepsis-related inflammation and become highly activated by a wide array of ligands on the site. The triggering receptor expressed on myeloid cells-1 (TREM-1) is a recently described receptor that has many effects on human PMN. The engagement of TREM-1 on PMN can induce phagocytosis, reactive oxygen species production and release of myeloperoxidase and IL-8. LPS has a priming effect on these functions. We show in this paper that Lyn, AKT, extracellular signal-regulated kinase 1/2 and Jak2 signaling pathways are elicited following TREM-1 engagement and activation by a monoclonal agonist antibody (anti-TREM-1) in human PMN, leading to the phosphorylation of STAT5 and RelA, a subunit of the nuclear factor-kappa B family. We also show that TREM-1 is recruited to ganglioside M1-lipid rafts in PMN upon stimulation with LPS or anti-TREM-1. Moreover, we observed that Toll-like receptor 4 and TREM-1 co-localize upon stimulation and TREM-1 engagement resulted in the phosphorylation of IL-1R-associated kinase 1, but not its stimulant-induced degradation. These data shed a new light on how various receptors implicated in the innate immune response could interact to insure an efficient inflammatory response upon pathogens-associated aggression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098818     DOI: 10.1093/intimm/dxl119

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  48 in total

Review 1.  Triggering receptor expressed on myeloid cells receptor family modulators: a patent review.

Authors:  Christopher J Pelham; Amit N Pandya; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2014-11-01       Impact factor: 6.674

2.  Tyrosine phosphorylation-independent regulation of lipopolysaccharide-mediated response by the transmembrane adaptor protein LAB.

Authors:  Minghua Zhu; Deirdre M Fuller; Chih-wen Ou-Yang; Sarah A Sullivan; Weiguo Zhang
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

3.  MT6-MMP is present in lipid rafts and faces inward in living human PMNs but translocates to the cell surface during neutrophil apoptosis.

Authors:  Carl F Fortin; Anjum Sohail; Qing Sun; Patrick P McDonald; Rafael Fridman; Tamàs Fülöp
Journal:  Int Immunol       Date:  2010-05-25       Impact factor: 4.823

4.  Silencing Triggering Receptors Expressed on Myeloid Cells-1 Impaired the Inflammatory Response to Oxidized Low-Density Lipoprotein in Macrophages.

Authors:  Houxuan Li; Feifei Hong; Shengbo Pan; Lang Lei; Fuhua Yan
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 5.  Platelets and innate immunity.

Authors:  John W Semple; John Freedman
Journal:  Cell Mol Life Sci       Date:  2009-12-18       Impact factor: 9.261

Review 6.  Kidney transplantation and the ageing immune system.

Authors:  Dianne McKay; Julie Jameson
Journal:  Nat Rev Nephrol       Date:  2012-11-13       Impact factor: 28.314

7.  Significant association of TREM-1 with HMGB1, TLRs and RAGE in the pathogenesis of insulin resistance in obese diabetic populations.

Authors:  Saravanan Subramanian; Pradeep K Pallati; Poonam Sharma; Devendra K Agrawal; Kalyana C Nandipati
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

8.  TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.

Authors:  Qisheng Peng; Shikha Malhotra; James A Torchia; William G Kerr; K Mark Coggeshall; Mary Beth Humphrey
Journal:  Sci Signal       Date:  2010-05-18       Impact factor: 8.192

9.  Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases.

Authors:  Marc Derive; Frédéric Massin; Sébastien Gibot
Journal:  Self Nonself       Date:  2010-07-02

10.  Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis.

Authors:  Naomi-Liza Denning; Monowar Aziz; Atsushi Murao; Steven D Gurien; Mahendar Ochani; Jose M Prince; Ping Wang
Journal:  JCI Insight       Date:  2020-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.